Risk factors of venous thromboembolism (VTE) in Thai reproductive aged female: King Chulalongkorn Memorial Hospital experience

Journal of the Medical Association of Thailand

Volumn 88, Issue 11, 2005, Pages 1502-1505

  Worralurt, Chatchadaporn ^a   Taneepanichskul, Surasak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Risk factors; Venous thromboembolism

Indexed keywords

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTRACEPTION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; FEMALE; HOSPITAL; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; OVARY CYCLE; QUESTIONNAIRE; SMOKING; VENOUS THROMBOEMBOLISM; CASE CONTROL STUDY; DRINKING BEHAVIOR; MIDDLE AGED; RISK FACTOR; THAILAND; UNIVERSITY HOSPITAL; VEIN THROMBOSIS;

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ALCOHOL DRINKING; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MIDDLE AGED; PULMONARY EMBOLISM; QUESTIONNAIRES; RISK FACTORS; SMOKING; THAILAND; VENOUS THROMBOSIS;

EID: 33645220069     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Heit JA, Silverstein MD, Mohr DN. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-63.
2. Rodger L, Bick MD. Cancer-associated thrombosis. N Engl J Med 2003; 349: 109-11.
3. Vandenbrouke JP, Rosing J, Bloemenkamp KWM, Helmerhorst FM, Bouma B, Rosendaal FR. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001; 344: 1527-35.
4. Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: the Study of Men Born in 1913. Arch Intern Med 1999; 159: 1886-90.
5. Tuut M, Hense HW. Smoking, other risk factors and fibrinogen levels: evidence of effect modification. Ann Epidemiol 2001; 11: 232-8.
6. Nightingale AL, Farmer RD. Ischemic stroke in young women. Stroke 2004; 35: 1574-8.
7. World Health Organisation. World Health Organisation Collaborative Study of cardiovascular disease and steroid hormone contraception. Venous thromboembolic disease and combined oral contraceptive: results of international multicentre case control study. Lancet 1995; 364: 1575-82.
8. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-93.
9. Jick H, Kaye JA, Vasilakis-Scaramozza C, Jick S. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case control analysis. Br Med J 2000; 321: 1190-5.
10. Heinemann LAJ, Lewis MA, Spitzer WO, Thorogood M, Guggenmoos-Holzman I, Bruppacher R. The Transnational Research Group on Oral Contraceptives and the Health of Young Women. Thromboembolic stroke in young women. A European case-control study on oral contraceptives. Contraception 1998; 57: 29-37.
11. Chuansumrit A, Jarutwachirakul W, Sasanakul W, Rurgkhum S, Kadegasem P, Kitpoka P, et al. Absence of factor V Arg306 - The and low factor V Arg306 - Gly mutation prevalence in Thai blood donors. Southeast Asian J Trop Med Public Health 2004; 35: 450-2.